TOKYO – Despite numerous obstacles standing in the way of companies making progress, Japan's biosimilars market is likely to grow in the coming years, driven both by rising awareness of the value of no-brand drugs and an industry body that is driving growth. Read More

The Albert and Mary Lasker Foundation announced that the 2016 Albert Lasker Basic Medical Research Award was shared by William Kaelin of the Dana-Farber Cancer Institute, Peter Ratcliffe of the University of Oxford's Francis Crick Institute, and Gregg Semenza of Johns Hopkins University School of Medicine "for the discovery of the pathway by which cells from humans and most animals sense and adapt to changes in oxygen availability." Read More

SHANGHAI – China's regulatory authorities have given Beigene Co. Ltd., the green light to study BGB-A317, a fully human PD-1 antibody, on patients in China. But this is not the first time BGB-A317 will be tested in a phase I trial. Read More

Daiichi Sankyo Inc., part of Daiichi Sankyo Co. Ltd., of Tokyo, named Marielle Cohard-Radice executive vice president, global head of development. Cohard-Radice will have responsibility for the development strategy and portfolio planning for the cardiovascular-metabolism and internal medicine therapeutic areas, and her team will be responsible for supporting the oncology clinical development group. Read More

Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, said it vaccinated the first subject in TIDES (Tetravalent Immunization against Dengue Efficacy Study), a phase III double-blind, randomized and placebo-controlled trial of its live-attenuated tetravalent dengue vaccine candidate, TAK-003. The study will enroll about 20,000 healthy children between the ages of 4 and 16 living in dengue-endemic countries in Latin America and Asia. Read More

NEW DELHI – India's drug regulator has made it mandatory for employees of drug manufacturing companies to be certified by a government body over the next 15 months. Read More